HOVILPRI

Live / Registered — Registered (as of 22 Oct 2024)

What this means for you

Registered since 22 Oct 2024. The owner can stop confusingly similar uses in the classes it covers.

Record

Serial number: 79372254
Registration number: 7539866
Mark type: Stylized text
Filed: 23 Mar 2023
Published for opposition: 06 Aug 2024
Registered: 22 Oct 2024
Attorney of record: F. William McLaughlin

Goods and services

Class 005 — Pharmaceuticals: Antivirals; antivirals for topical use; Medicine for treatment of infectious diseases, viral infections, herpes simplex virus infections, Medicine for prophylaxis of infectious diseases, viral infections, herpes simplex virus infections; Medicines for treatment of infectious diseases, viral infections, herpes simplex virus infections for human purposes, Medicines for prophylaxis of infectious diseases, viral infections, herpes simplex virus infections for human purposes; Medicines for treatment of viral infections for veterinary purposes; Medicines for dental purposes; medicated eye lotions for medical use; medicated eye ointment for medical use; Creams for dermatological use; Dermatological-pharmaceutical products; Medicated lip creams; Medicated skin creams; Medicated skin lotions; Medicinal preparations for the treatment of infectious diseases; Medicated ointments for application to the skin for treating dermatological conditions; Medicated preparations for treating dermatological conditions; Medicated ointments for treating dermatological conditions; medicated preparations for the treatment of herpes of the lips; Ophthalmological preparations; Ophthalmic preparations; Ophthalmologic preparations; Pharmaceutical preparations for ophthalmological use; Pharmaceutical preparations for use in ophthalmology; Pharmaceutical products for ophthalmological use; Topical ophthalmic anti-infective substances for the treatment of infections; Pharmaceutical preparations for treating skin disorders; Pharmaceutical preparations for the treatment of infectious diseases; Pharmaceutical lip ointments; Pharmaceutical preparations for use in dermatology; Pharmaceutical preparations and substances for use in gynecology; Pharmaceutical preparations and substances for use in urology; Pharmaceutical preparations for the treatment of viral diseases; Pharmaceutical preparations for the treatment of diseases of the genitourinary system; Pharmaceutical preparations for the prevention of diseases of the genitourinary system; Pharmaceutical preparations for skin wounds; Sulfonamides being medicines; Sulfonamide preparations; Transdermal patches for medical treatment of infectious diseases, viral infections, herpes simplex virus infections; Pharmaceutical lipsalves; Antiviral drugs for treating herpes simplex virus infections; Preparations for the treatment of genital herpes; Medicinal preparations for the treatment of herpes simplex virus infections; medicinal preparations for the treatment of labial herpes; medicinal preparations for the treatment of mucosal herpes; Pharmaceutical preparations for the treatment of herpes simplex virus infections; Pharmaceutical preparations for skin lesions; Sulfonamides for treatment of infectious diseases, viral infections, herpes simplex virus infections, Sulfonamides for prophylaxis of infectious diseases, viral infections, herpes simplex virus infections, Salts of sulfonamides for treatment of infectious diseases, viral infections, herpes simplex virus infections, Salts of sulfonamides for prophylaxis of infectious diseases, viral infections, herpes simplex virus infections; Pharmaceutical formulations in the form of tablets for treatment of infectious diseases, viral infections, herpes simplex virus infections, Pharmaceutical formulations in the form of tablets for prophylaxis of infectious diseases, viral infections, herpes simplex virus infections; Pharmaceutical formulations in the form of solutions for treatment of infectious diseases, viral infections, herpes simplex virus infections, Pharmaceutical formulations in the form of solutions for prophylaxis of infectious diseases, viral infections, herpes simplex virus infections; Pharmaceutical formulations in the form of suspensions for treatment of infectious diseases, viral infections, herpes simplex virus infections, Pharmaceutical formulations in the form of suspensions for prophylaxis of infectious diseases, viral infections, herpes simplex virus infections; Pharmaceutical formulations for intra-veneous application for treatment of infectious diseases, viral infections, herpes simplex virus infections, Pharmaceutical formulations for intra-veneous application for prophylaxis of infectious diseases, viral infections, herpes simplex virus infections; Antiviral drugs for treating of sexually transmittable diseases; Medicinal preparations for the treatment of sexually transmittable diseases.
Class 010 — Medical apparatus: Medical devices for intra-vaginal use for treatment of infectious diseases, viral infections, herpes simplex virus infections; Medical devices for intra-vaginal use for prophylaxis of infectious diseases, viral infections, herpes simplex virus infections; medical devices for intra-vaginal application of anti-virals; medical devices for intra-vaginal application of sulfonamides
Class 041 — Education and entertainment services: Organization of seminars and conventions in the field of medicine; Publication of scientific information journals; publishing of online electronic publications; publishing of electronic publications; providing education courses in the field of science; Organization of seminars and conventions in the field of virology.
Class 044 — Medical, beauty and agricultural services: Pharmaceutical consultancy services; consultancy and information services relating to medical products; providing health information; information services relating to health care; provision of health information; medical information services provided via the internet

Owner

Prosecution history

05 Mar 2026 — NEW REPRESENTATIVE AT IB RECEIVED
12 Apr 2025 — FINAL DECISION TRANSACTION PROCESSED BY IB
26 Mar 2025 — FINAL DISPOSITION NOTICE SENT TO IB
26 Mar 2025 — FINAL DISPOSITION PROCESSED
22 Jan 2025 — FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB
22 Oct 2024 — NOTICE OF REGISTRATION CONFIRMATION EMAILED
22 Oct 2024 — REGISTERED-PRINCIPAL REGISTER
06 Aug 2024 — OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
06 Aug 2024 — PUBLISHED FOR OPPOSITION
17 Jul 2024 — NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
27 Jun 2024 — APPROVED FOR PUB - PRINCIPAL REGISTER
20 Jun 2024 — TEAS/EMAIL CORRESPONDENCE ENTERED
20 Jun 2024 — CORRESPONDENCE RECEIVED IN LAW OFFICE
20 Jun 2024 — TEAS RESPONSE TO OFFICE ACTION RECEIVED
23 Jan 2024 — REFUSAL PROCESSED BY IB

View this trademark record on Marksy